Connection
Corneliu Bolbocean to Quality-Adjusted Life Years
This is a "connection" page, showing publications Corneliu Bolbocean has written about Quality-Adjusted Life Years.
|
|
Connection Strength |
|
|
|
|
|
0.060 |
|
|
|
-
Cressman S, Karsan A, Hogge DE, McPherson E, Bolbocean C, Regier DA, Peacock SJ. Economic impact of genomic diagnostics for intermediate-risk acute myeloid leukaemia. Br J Haematol. 2016 08; 174(4):526-35.
Score: 0.033
-
Johnston KM, Bolbocean C, Connors J, Peacock S. Cost-effectiveness of rituximab in follicular lymphoma. Expert Rev Pharmacoecon Outcomes Res. 2012 Oct; 12(5):569-77.
Score: 0.026